Garuda Therapeutics’ Launch and $72 Million Series A Financing

Goodwin Procter advised Garuda Therapeutics on the deal.Garuda Therapeutics announced its launch and $72 million Series A financing led by Aisling Capital, Northpond Ventures, and OrbiMed, and…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now